Abstract
Cross-sectional studies suggest self-reported cancer history is associated with decreased risk of Alzheimer's disease (AD). However, little is known about how self-reported cancer affects longitudinal AD progression, the primary outcome in clinical trials and observational studies. To determine self-reported cancer history's effect on longitudinal AD progression in an observational study. We utilized data from the Alzheimer's Disease Neuroimaging Initiative (ADNI) to evaluate progression to AD by self-reported all-cancer, breast, prostate, colorectal, or non-melanoma skin cancer history. Linear mixed effects models were used to examine baseline differences and rates of progression on the Alzheimer's Disease Assessment Scale-Cognitive Subscale (ADAS-Cog) by self-reported cancer history. Age at AD onset was examined using consensus clinical diagnoses with Cox proportional hazards regression. Among 1,271 participants, models revealed no significant differences in progression over time but did reveal significantly lower baseline ADAS-Cog score, indicating better cognition at a given age in those with self-reported cancer history. Cox models indicated those with self-reported cancer history had significantly later age of AD onset (H...Continue Reading
References
Nov 1, 1984·The American Journal of Psychiatry·W G RosenK L Davis
Jul 1, 1984·Neurology·G McKhannE M Stadlan
Nov 1, 1995·Mayo Clinic Proceedings·K C FlemingR C Petersen
Apr 1, 1998·American Journal of Epidemiology·M M BergmannC W Heath
Aug 25, 2004·Journal of Internal Medicine·R C Petersen
Mar 9, 2005·Neurology·C M RoeJ C Morris
Nov 30, 2006·Cancer·Masatoshi InagakiYosuke Uchitomi
Sep 16, 2009·Alzheimer's & Dementia : the Journal of the Alzheimer's Association·Lon S Schneider, Mary Sano
Dec 25, 2009·Neurology·C M RoeJ C Morris
Jan 1, 2010·Neurology·R C PetersenM W Weiner
Mar 14, 2012·BMJ : British Medical Journal·Jane A DriverPhillip A Wolf
Sep 12, 2012·Current Alzheimer Research·Richard E KennedyUNKNOWN Alzheimer's Disease Neuroimaging Initiative
Dec 12, 2012·Cancer Treatment Reviews·Kristy D HodgsonTed Nettelbeck
May 29, 2013·Alzheimer's & Dementia : the Journal of the Alzheimer's Association·Richard E KennedyLon S Schneider
Jul 12, 2013·Neurology·Massimo MusiccoAntonio Russo
Jan 30, 2014·BMC Geriatrics·Kathrin BauerRolf Holle
Apr 11, 2014·International Review of Psychiatry·Michelle C JanelsinsGary R Morrow
Nov 18, 2014·Frontiers in Physiology·Kelly N H NudelmanUNKNOWN Alzheimer's Disease Neuroimaging Initiative
Feb 15, 2015·Neurology·Lon S SchneiderGary R Cutter
Feb 3, 2016·Journal of Alzheimer's Disease : JAD·Richard E KennedyLon S Schneider
Sep 18, 2016·Handbook of Clinical Neurology·P Jean-Pierre, B C McDonald
Jun 1, 2015·Alzheimer's & Dementia : Translational Research & Clinical Interventions·Richard E KennedyLon S Schneider
Aug 2, 2017·Cancer Epidemiology·Sooyoung ChoJong-Koo Lee
Oct 11, 2017·The Medical Clinics of North America·Tracy D Vannorsdall
Jan 16, 2019·JAMA Network Open·Alison R HuangSusan J Lapham
Jan 16, 2019·JAMA Network Open·Richard E KennedyLon S Schneider
Jan 3, 2020·Nuclear Medicine Communications·Sara Pourhassan ShamchiAbass Alavi